Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Shares Issued (2022 - 2026)

HeartSciences (HSCS) has disclosed Shares Issued for 4 consecutive years, with $171276.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Issued rose 101.8% year-over-year to $171276.0, compared with a TTM value of $1.1 million through Apr 2025, up 112.98%, and an annual FY2025 reading of $1.1 million, up 243.33% over the prior year.
  • Shares Issued was $171276.0 for Q2 2025 at HeartSciences, down from $251436.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $5.2 million in Q4 2022 and bottomed at -$9.5 million in Q2 2024.
  • Average Shares Issued over 4 years is -$767786.0, with a median of $211356.0 recorded in 2025.
  • Peak annual rise in Shares Issued hit 2172.17% in 2023, while the deepest fall reached 94.59% in 2023.
  • Year by year, Shares Issued stood at $5.2 million in 2022, then plummeted by 94.59% to $279944.0 in 2023, then plummeted by 56.73% to $121120.0 in 2024, then surged by 41.41% to $171276.0 in 2025.
  • Business Quant data shows Shares Issued for HSCS at $171276.0 in Q2 2025, $251436.0 in Q1 2025, and $121120.0 in Q4 2024.